Peptides DB
Research-centric peptide and protocol reference hub
Study 8 of 10Teriparatide (PTH 1-34) literatureInfectious Disease Modelling · Observational2027

From giant components to communities: community-level insights for prioritizing interventions within large clusters of HIV-1 transmission networks.

Partitioning large HIV-1 transmission clusters into smaller communities may improve targeted intervention strategies.

Read at Infectious Disease ModellingAdd to compare

Where it sits

this study against the rest of the teriparatide (pth 1-34) corpus
0
Preclinical
9
Observational · this one
0
Open-label
1
Randomised
0
Reviews

Summary and findings

This study developed an analytical framework to partition a large HIV-1 transmission cluster into smaller communities for targeted interventions. The research focused on the HIV-1 CRF07_BC molecular transmission network in Guangzhou, China, from 2008 to 2020. The findings suggest that Community 1 is the likely ancestral source of the giant component.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
681 members in the giant component identified.n=6812027

Abstract

The authors’ words, as Infectious Disease Modelling supplied them

Large clusters in HIV-1 molecular networks contain a substantial proportion of people living with HIV and dominate local epidemics; however, their large size and complex structure pose a challenge for effective public health interventions. We developed an analytical framework to partition the large cluster into small groups for precise intervention. In the HIV-1 CRF07_BC molecular transmission network in Guangzhou, China (2008-2020), a giant component (681 members) was partitioned into 34 communities with dense internal and sparse external links. All 378 inter-community links involved high-centrality members from Community 1 (<i>P</i> < 0.001) and phylogenetic analysis identified Community 1 as the most likely ancestral source of the giant component (marginal probability = 0.989). Exponential random graph models (ERGMs) revealed significant homophily effect among members with specific characteristics in the giant component and its large communities, highlighting potential outbreaks within specific subgroups. Partitioning giant components into communities may be a promising approach to help develop community-level interventions and could improve the effectiveness of interventions targeted at large clusters.

Background

This paper addresses the challenge of effectively intervening in large clusters of HIV-1 transmission networks, which are known to contain a significant proportion of people living with HIV. Prior research has indicated that large clusters can dominate local epidemics, but their size and complexity complicate public health responses. The study aims to improve intervention strategies by partitioning these clusters into smaller, more manageable communities.

Methods

The study utilized an analytical framework to partition the HIV-1 CRF07_BC molecular transmission network in Guangzhou, China, over a period from 2008 to 2020. The population included members of the identified giant component, totaling 681 individuals. The primary outcome measures involved the identification of communities and the analysis of inter-community links using exponential random graph models (ERGMs).

Results

The primary finding was the identification of 681 members in the giant component, which was partitioned into 34 distinct communities. All 378 inter-community links involved high-centrality members from Community 1, with a statistical significance of p < 0.001. Phylogenetic analysis indicated that Community 1 had a marginal probability of 0.989 of being the ancestral source of the giant component.

Interpretation

The results suggest that partitioning large HIV-1 transmission clusters into smaller communities may enhance the effectiveness of targeted interventions. While the statistical significance of the findings is clear, the clinical implications of these community-level insights require further exploration. Limitations such as the specific geographic focus and the potential for unreported confounding factors may affect the generalizability of the conclusions.

Key findings

  • 681 members in the giant component identified.
  • 34 communities were formed from the giant component.
  • All 378 inter-community links involved high-centrality members from Community 1 (p < 0.001).
  • Marginal probability for Community 1 as the ancestral source was 0.989.

Limitations

  • Not reported in abstract.
  • Study focused on a specific geographic area (Guangzhou, China).
  • Potential confounding factors not addressed.

Elsewhere in the Teriparatide (PTH 1-34) corpus

BImpact of Preoperative Teriparatide Use on Proximal Junctional Kyphosis Prevention in Osteopenic/Osteoporotic Patients Undergoing Adult Spinal Deformity Surgery: A Propensity Score-Matched Studybiorxiv-preprint · 2026 · 44.2% PJK incidence in teriparatide group vs. 52.5% in non-teriparatide group, P = 0.426HumanBFragmented prevention in rural South Africa: a qualitative study of Biokineticists' perspectives on health system barriers to early detection of non-communicable diseases.Global health action · 2026 · n=10 · Not reported in abstract.HumanBPatients With Pancreatitis-Related Gene Variants Showed Higher Incidence of Hyperpancreatic Enzymemia After Endoscopic Retrograde Cholangiopancreatography.DEN open · 2023 · n=94 · Odds ratio for PEH in patients with PRG-variants was 6.291 (95% CI, 1.133-34.934).HumanBWhite Globe Appearance Is an Endoscopic Predictor of Metachronous Multiple Gastric Cancers.DEN open · 2023 · n=444 · Metachronous gastric cancers were significantly more frequent in the WGA-positive group, p<0.01.HumanBClinical Outcomes of Antrectomy for Patients With Multiple Type I Gastric Neuroendocrine Tumors: A Case Series.DEN open · 2023 · n=8 · Median preoperative serum gastrin levels were 4800 (range, 2400-11,000) pg/mL.HumanATeriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.JAMA · 2026 · 36.9% of participants in the teriparatide plus zoledronic acid group had incident fractures vs 36.4% in the standard care group, absolute risk reduction -1.57%, 95% CI -9.90% to 5.89%, hazard ratio 0.97, 95% CI 0.68 to 1.38.Human